Neuro, you know as well as I and many others, that Cortex moves independently of the overall market.
Longer term, I do like COR, but what's hanging me up is the coming FDA decision. We don't know of a certain what that decision is going to be. We don't know of a certain whether AMPAKINES will work as well as many people hope they will. I don't see any catalyst in the near term to make the stock price rise so I suspect the gradual downdrift that we've seen many times before to occur again.
If the FDA decision is favorable, I would expect significant gains. If not, a precipitous fall would probably ensue.
But now I'm getting overly redundant.